All entries for: Xencor Inc.

February 25, 2026

Xencor Inc.

Neutral Outlook

Pasadena, CA
201-500 employees

The current presidential administration is pursuing policies to reduce regulations and expenditures across government including at HHS, the FDA, CMS and related agencies. These actions, presently directed by executive orders or memoranda from the Office of Management and Budget, may propose policy changes that create additional uncertainty for our business. These actions and proposals may, for example, include… directing HHS and other agencies to lower prescription drug costs through a variety of initiatives, including by improving upon the Medicare Drug Price Negotiation Program and establishing Most-Favored-Nation pricing for pharmaceutical products

February 25, 2026

Xencor Inc.

Neutral Outlook

Pasadena, CA
201-500 employees

It is unclear how such challenges, and the healthcare reform measures of the current administration, will impact the ACA and our business.

Disease Area: Gastrointestinal, Immune Diseases, Oncology
Drug Type: Biologic
Scroll to Top